Use of endoluminal vacuum therapy after anastomotic leak in a gynecologic oncology patient with rectosigmoid resection: A case report

Divya Gowthaman; Lisa R Gabor; Ken Y Lin; Julie Yang; Gary A Dellacerra; Sara S Isani; Dennis Y Kuo

doi:10.1016/j.gore.2022.101113

Use of endoluminal vacuum therapy after anastomotic leak in a gynecologic oncology patient with rectosigmoid resection: A case report

Gynecol Oncol Rep. 2022 Dec 6:44:101113. doi: 10.1016/j.gore.2022.101113. eCollection 2022 Dec.

Authors

Divya Gowthaman^{1

2

3}, Lisa R Gabor^{1

2

3}, Ken Y Lin^{1

2

3}, Julie Yang^{1

2

3}, Gary A Dellacerra^{1

2

3}, Sara S Isani^{1

2

3}, Dennis Y Kuo^{1

2

3}

Affiliations

¹ Department of Obstetrics and Gynecology and Women's Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, 1300, Morris Park Avenue, USA.
² Department of Medicine, Division of Gastroenterology, Albert Einstein College of Medicine, Montefiore Medical Center, 1300, Morris Park Avenue, USA.
³ Department of Radiology, Division of Abdominal Radiology, Albert Einstein College of Medicine, Montefiore Medical Center, 1300 Morris Park Avenue, USA.

Abstract

•Anastomotic leak is an infrequent complication after colon resection and is associated with high morbidity and mortality.•Endoluminal vacuum therapy (EVAT) promotes wound closure by covering anastomotic leaks intraluminally and applying vacuum.•EVAT has been shown to be safe with mild adverse events.•EVAT should be considered in hemodynamically stable gynecologic oncology patients with a confined anastomotic leak.

Publication types

Case Reports